Astra Industrial Group Company SJSC

Astra Industrial Group Company SJSC maintains a conservative capital structure with a debt-to-equity ratio of 0.08, indicating minimal leverage relative to its equity base of 2.96 billion SAR. The company holds 6.53 million SAR in cash and equivalents against 232.87 million SAR in long-term debt, resulting in a net cash position that is technically negative when total debt is considered, which contributes to a medium liquidity risk assessment. Despite the low cash balance, the current ratio stands at 1.64, suggesting adequate short-term liquidity to cover immediate obligations. Operating cash flow of 727.65 million SAR significantly exceeds free cash flow of 364.14 million SAR, reflecting substantial capital expenditures of 152.54 million SAR during the period.

Profitability metrics demonstrate strong operational efficiency, with a return on equity of 22.56% and a return on assets of 15.1%. The company generated 666.81 million SAR in net income from 3.07 billion SAR in revenue, yielding a net margin of approximately 21.7%. Gross profit of 1.41 billion SAR indicates a gross margin of roughly 46%, while operating income of 694.69 million SAR suggests effective cost control and operational leverage. These returns are robust, though specific cohort median comparisons are not provided in the available data to benchmark against industry peers.

Revenue concentration and geographic exposure details are not explicitly broken down in the provided financial snapshot, limiting the ability to assess segment-specific risks or regional dependencies. The company’s activity is broadly classified under Pharmaceuticals & Medical Research, implying a diversified product mix within the healthcare domain, but specific segment revenue contributions are absent from the current dataset. Without detailed segment data, the analysis relies on aggregate financial performance to infer business stability.

Growth trajectory analysis is constrained by the absence of historical period data in the input, preventing a year-over-year or quarter-over-quarter trend assessment. The current financial snapshot provides a static view of performance, with no prior period comparisons available to evaluate revenue acceleration or deceleration. Consequently, the growth narrative is limited to the current period’s absolute figures, which show a healthy bottom line but lack temporal context for trend validation.

Risk factors include a medium liquidity rating and a key flag noting that net cash is negative after subtracting total debt, which may constrain financial flexibility despite low leverage. Dilution risk is assessed as low, with basic and diluted shares outstanding both at 80 million, indicating no significant options or convertible securities impacting share count. The absence of strong buy or buy recommendations from analysts, with a mean recommendation of 4.00 (neutral/sell), suggests market skepticism or limited upside potential in the current valuation.

Recent events and observations are limited to analyst estimates, with a mean price target of 144.12 SAR and a median target of 144.12 SAR, ranging from a low of 124.25 SAR to a high of 164.00 SAR. The mean recommendation of 4.00 indicates a neutral to bearish sentiment among analysts, with no strong buy or buy ratings recorded. No specific filing, news, or transcript observations are provided to contextualize recent corporate actions or strategic shifts.

Long-term debt decreased significantly to SAR 233 million in FY2026, reflecting a strong deleveraging trend from previous years.

Free cash flow improved to SAR 364 million in FY2026, demonstrating enhanced cash generation capabilities compared to prior periods.

The four-year revenue CAGR stands at negative 4.7%, highlighting a persistent long-term decline in sales volume.

Analysts currently assign a sell recommendation to the stock, suggesting limited near-term upside potential for investors.

The company faces a medium level of liquidity risk, which could constrain operational flexibility during market stress.

Revenue SAR 790.9M, −5,1% YoY; Operating income +1,5% YoY.

• ▍Revenue SAR 790.9M, −5,1% YoY
• ▍Operating income +1,5% YoY
• ▍Net income +0,7% YoY
• ▍Free cash flow −10,1% YoY
• ▍Net margin 21.9%

Revenue SAR 791.8M, +9,7% YoY; Operating income −26,0% YoY.

• ▍Revenue SAR 791.8M, +9,7% YoY
• ▍Operating income −26,0% YoY
• ▍Net income +16,1% YoY
• ▍Free cash flow −25,7% YoY
• ▍Net margin 19.3%

Revenue SAR 730.1M, +6,0% YoY; Operating income +10,8% YoY.

• ▍Revenue SAR 730.1M, +6,0% YoY
• ▍Operating income +10,8% YoY
• ▍Net income +20,1% YoY
• ▍Free cash flow +23,1% YoY
• ▍Net margin 22.9%

Revenue SAR 715.1M, −12,7% YoY; Operating income +24,7% YoY.

• ▍Revenue SAR 715.1M, −12,7% YoY
• ▍Operating income +24,7% YoY
• ▍Net income +3,7% YoY
• ▍Free cash flow +33,1% YoY
• ▍Net margin 24.5%

Revenue SAR 833.7M; Operating income SAR 189.3M.

• ▍Revenue SAR 833.7M
• ▍Operating income SAR 189.3M
• ▍Net margin 20.6%

Revenue SAR 721.6M; Operating income SAR 161.8M.

• ▍Revenue SAR 721.6M
• ▍Operating income SAR 161.8M
• ▍Net margin 18.2%

Revenue SAR 688.5M; Operating income SAR 164.4M.

• ▍Revenue SAR 688.5M
• ▍Operating income SAR 164.4M
• ▍Net margin 20.2%

Revenue SAR 819.1M; Operating income SAR 163.3M.

• ▍Revenue SAR 819.1M
• ▍Operating income SAR 163.3M
• ▍Net margin 20.6%

Revenue SAR 3.07B, +0,3% YoY; Operating income +5,5% YoY.

• ▍Revenue SAR 3.07B, +0,3% YoY
• ▍Operating income +5,5% YoY
• ▍Net income +13,2% YoY
• ▍Free cash flow +94,5% YoY
• ▍Net margin 21.7%

Revenue SAR 3.06B, +8,6% YoY; Operating income +23,5% YoY.

• ▍Revenue SAR 3.06B, +8,6% YoY
• ▍Operating income +23,5% YoY
• ▍Net income +24,0% YoY
• ▍Free cash flow −39,7% YoY
• ▍Net margin 19.2%

Revenue SAR 2.82B, +8,7% YoY; Operating income +34,8% YoY.

• ▍Revenue SAR 2.82B, +8,7% YoY
• ▍Operating income +34,8% YoY
• ▍Net income +0,2% YoY
• ▍Free cash flow +49,7% YoY
• ▍Net margin 16.9%